ROMEOVILLE, Ill., March 07, 2025 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories, today announced its rebranding as Solésence, Inc., marking a new chapter in its commitment to innovation, self-expression, and inclusivity in skin health.
The rebranding underscores the success of the company’s beauty science platform, which has revolutionized mineral-based sun and environmental protection since earning a patent in 2015 for its Active Stress Defense™ Technology. The platform has driven strategic growth since 2020, and the company remains confident in its ability to sustain rapid and profitable expansion in the years ahead.
“Solésence embodies our relentless commitment to innovation and our belief that beauty should empower and protect,” said Jess Jankowski, President, Chief Executive Officer and Chief Financial Officer. “The versatility of Solésence technologies, combined with our path to market through dozens of beauty brands across categories and price segments, enables the realization of a mission beyond what we could achieve as a single consumer brand. This is more than a rebrand—it’s a declaration of our future and a milestone that reflects the incredible work of our dedicated team members who work tirelessly in pursuit of our mission and have fueled the company’s success.”
Since the first Solésence brand partner product launch in 2018, the company has supported dozens of beauty brands across skin care, sun care, and color cosmetics categories on a global basis. Also throughout this period, the company has expanded its suite of transformative technologies, integrating novel skin health benefits into beauty products while earning industry accolades for innovation, product performance, and service. The company continues to push the boundaries of skincare and color cosmetics by merging scientific excellence with human-centered design to ensure a positive product experience across the full range of human beauty.
“For years, Solésence has led the effort to address our industry’s widely held belief that the number one cause of skin damage is UV light,” said Kevin Cureton, Chief Operating Officer. “Our rebranding recommits our organization to our mission—to deliver joy through the science of beautiful skin. As we look ahead, we remain dedicated to expanding our capabilities, strengthening our partnerships, and ensuring that everyone has access to best-in-class skin health solutions that address concerns, such as skin cancer and skin aging.”
The company’s stock will continue to trade under the NANX ticker symbol. Its corporate website will transition to solesence.com, while investor relations information, including historic Nanophase financials and disclosures, will be available at nanophase.com until the transition is complete.
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 28, 2024. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.
Investor Relations Contact:
investors@solesence.com
(630) 771-6736
Media Contact:
